Documento fuente o registro público

FDA 510(k) K201570 — PF4 Enhanced assay

FDA 510(k) index record K201570. Device: PF4 Enhanced assay. Applicant as listed: Immucor Gti Diagnostics, Inc.. Decision date: 2020-09-11.

OtherU.S. Food and Drug Administration (FDA)2020-09-11

Fuente

"device_name": "PF4 Enhanced assay"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K201570.

Device name: PF4 Enhanced assay. Applicant as listed: Immucor Gti Diagnostics, Inc..

Decision date: 2020-09-11. Decision wording: Substantially Equivalent.

Product code: LCO. Regulation: 21 CFR 864.7695. Medical specialty: Hematology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más